|
1.
|
Johnson CC, Hayes RB, Schoen RE, Gunter MJ
and Huang WY; PLCO Trial Team: Non-steroidal anti-inflammatory drug
use and colorectal polyps in the Prostate, Lung, Colorectal, and
Ovarian Cancer Screening Trial. Am J Gastroenterol. 105:2646–2655.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Harris RE, Beebe-Donk J and Alshafie GA:
Similar reductions in the risk of human colon cancer by selective
and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer.
8:2372008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Harris RE, Beebe-Donk J, Doss H and Burr
Doss D: Aspirin, ibuprofen, and other non-steroidal
anti-inflammatory drugs in cancer prevention: a critical review of
non-selective COX-2 blockade (Review). Oncol Rep. 13:559–583.
2005.
|
|
4.
|
Cioli V, Putzolu S, Rossi V and Corradino
C: A toxicological and pharmacological study of ibuprofen guaiacol
ester (AF 2259) in the rat. Toxicol Appl Pharmacol. 54:332–339.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Venuti MC, Young JM, Maloney PJ, Johnson D
and McGreevy K: Synthesis and biological evaluation of
omega-(N,N,N-trialkylammonium)alkyl esters and thioesters of
carboxylic acid nonsteroidal antiinflammatory agents. Pharm Res.
6:867–873. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Samara E, Avnir D, Ladkani D and Bialer M:
Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen
and naproxen. Biopharm Drug Dispos. 16:201–210. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Abordo EA, Bowden K, Huntington AP and
Powell SL: Prodrugs. Part 3. 2-Formylphenyl esters of indomethacin,
ketoprofen and ibuprofen and 6-substituted 2-formyl and
2-acylphenyl esters of aspirin. Farmaco. 53:95–101. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Mahfouz NM, Omar FA and Aboul-Fadl T:
Cyclic amide derivatives as potential prodrugs II:
N-hydroxymethylsuccinimide-/isatin esters of some NSAIDs as
prodrugs with an improved therapeutic index. Eur J Med Chem.
34:551–562. 1999. View Article : Google Scholar
|
|
9.
|
Kahns AH, Jensen PB, Mork N and Bundgaard
H: Kinetics of hydrolysis of indomethacin and indomethacin ester
prodrugs in aqueous solution. Acta Pharm Nord. 1:327–336.
1989.PubMed/NCBI
|
|
10.
|
Wang LF, Chiang HN and Wu PC: Kinetics and
hydrolysis mechanism of polymeric prodrugs containing ibuprofen,
ketoprofen, and naproxen as pendent agents. J Biomater Sci Polym
Ed. 13:287–299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Peng YS, Lin SC, Huang SJ, et al:
Chondroitin sulfate-based anti-inflammatory macromolecular
prodrugs. Eur J Pharm Sci. 29:60–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zhao X, Tao X, Wei D and Song Q:
Pharmacological activity and hydrolysis behavior of novel ibuprofen
glucopyranoside conjugates. Eur J Med Chem. 41:1352–1358. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kourounakis PN, Tsiakitzis K, Kourounakis
AP and Galanakis D: Reduction of gastrointestinal toxicity of
NSAIDs via molecular modifications leading to antioxidant
anti-inflammatory drugs. Toxicology. 144:205–210. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Galanakis D, Kourounakis AP, Tsiakitzis
KC, et al: Synthesis and pharmacological evaluation of amide
conjugates of NSAIDs with L-cysteine ethyl ester, combining potent
antiinflammatory and antioxidant properties with significantly
reduced gastrointestinal toxicity. Bioorg Med Chem Lett.
14:3639–3643. 2004. View Article : Google Scholar
|
|
15.
|
Yeh RK, Chen J, Williams JL, et al:
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit
colon cancer cell growth more potently than traditional NSAIDs: a
general pharmacological property? Biochem Pharmacol. 67:2197–2205.
2004. View Article : Google Scholar
|
|
16.
|
Kashfi K, Ryan Y, Qiao LL, et al: Nitric
oxide-donating nonsteroidal anti-inflammatory drugs inhibit the
growth of various cultured human cancer cells: evidence of a tissue
type-independent effect. J Pharmacol Exp Ther. 303:1273–1282. 2002.
View Article : Google Scholar
|
|
17.
|
Williams JL, Borgo S, Hasan I, Castillo E,
Traganos F and Rigas B: Nitric oxide-releasing nonsteroidal
anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon
cancer cell lines more effectively than traditional NSAIDs:
implications for colon cancer chemoprevention. Cancer Res.
61:3285–3289. 2001.
|
|
18.
|
Mattheolabakis G, Nie T, Constantinides PP
and Rigas B: Sterically stabilized liposomes incorporating the
novel anti-cancer agent phospho-ibuprofen (MDC-917): preparation,
characterization, and in vitro/in vivo evaluation. Pharm Res.
29:1435–1443. 2012. View Article : Google Scholar
|
|
19.
|
Sun Y, Huang L, Mackenzie GG and Rigas B:
Oxidative stress mediates through apoptosis the anticancer effect
of phosphononsteroidal anti-inflammatory drugs: implications for
the role of oxidative stress in the action of anticancer agents. J
Pharmacol Exp Ther. 338:775–783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Xie G, Sun Y, Nie T, et al:
Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer:
efficacy, metabolism, and pharmacokinetics in mouse models. J
Pharmacol Exp Ther. 337:876–886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Huang L, Mackenzie G, Ouyang N, et al: The
novel phosphonon-steroidal anti-inflammatory drugs, OXT-328, MDC-22
and MDC-917, inhibit adjuvant-induced arthritis in rats. Br J
Pharmacol. 162:1521–1533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Wong CC, Cheng KW, Xie G, et al:
Carboxylesterases 1 and 2 hydrolyze phospho-NSAIDs: relevance to
their pharmacological activity. J Pharmacol Exp Ther. 340:422–432.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Piazza GA, Keeton AB, Tinsley HN, et al: A
novel sulindac derivative that does not inhibit cyclooxygenases but
potently inhibits colon tumor cell growth and induces apoptosis
with antitumor activity. Cancer Prev Res (Phila). 2:572–580. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Bird RP: Observation and quantification of
aberrant crypts in the murine colon treated with a colon
carcinogen: preliminary findings. Cancer Lett. 37:147–151. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Natarajan K, Singh S, Burke TR Jr,
Grunberger D and Aggarwal BB: Caffeic acid phenethyl ester is a
potent and specific inhibitor of activation of nuclear
transcription factor NF-kappaB. Proc Natl Acad Sci USA.
93:9090–9095. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Williams JL, Ji P, Ouyang N, Liu X and
Rigas B: NO-donating aspirin inhibits the activation of NF-kappaB
in human cancer cell lines and Min mice. Carcinogenesis.
29:390–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Shanbhag VR, Crider AM, Gokhale R,
Harpalani A and Dick RM: Ester and amide prodrugs of ibuprofen and
naproxen: synthesis, anti-inflammatory activity, and
gastrointestinal toxicity. J Pharm Sci. 81:149–154. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Antonakopoulos N and Karamanolis DG: The
role of NSAIDs in colon cancer prevention. Hepatogastroenterology.
54:1694–1700. 2007.PubMed/NCBI
|
|
29.
|
Backlund MG, Mann JR and Dubois RN:
Mechanisms for the prevention of gastrointestinal cancer: the role
of prostaglandin E2. Oncology. 69(Suppl 1): 28–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Koki A, Khan NK, Woerner BM, et al:
Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol.
507:177–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Koch A, Gustafsson B, Fohlin H and
Sorenson S: Cyclooxygenase-2 expression in lung cancer cells
evaluated by immunocytochemistry. Diagn Cytopathol. 39:188–193.
2011.PubMed/NCBI
|
|
32.
|
Schoen RT and Vender RJ: Mechanisms of
nonsteroidal anti-inflammatory drug-induced gastric damage. Am J
Med. 86:449–458. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Mitchell JA and Warner TD:
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and
relevance to NSAID therapy. Br J Pharmacol. 128:1121–1132. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Wallace JL and Cirino G: The development
of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs.
Trends Pharmacol Sci. 15:405–406. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Kardosh A, Blumenthal M, Wang WJ, Chen TC
and Schonthal AH: Differential effects of selective COX-2
inhibitors on cell cycle regulation and proliferation of
glioblastoma cell lines. Cancer Biol Ther. 3:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Narayanan BA, Condon MS, Bosland MC,
Narayanan NK and Reddy BS: Suppression of
N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer
growth by celecoxib: effects on cyclooxygenase-2, cell cycle
regulation, and apoptosis mechanism(s). Clin Cancer Res.
9:3503–3513. 2003.
|
|
37.
|
Grosch S, Tegeder I, Niederberger E,
Brautigam L and Geisslinger G: COX-2 independent induction of cell
cycle arrest and apoptosis in colon cancer cells by the selective
COX-2 inhibitor celecoxib. FASEB J. 15:2742–2744. 2001.PubMed/NCBI
|
|
38.
|
Maier TJ, Schilling K, Schmidt R,
Geisslinger G and Grosch S: Cyclooxygenase-2 (COX-2)-dependent and
-independent anti-carcinogenic effects of celecoxib in human colon
carcinoma cells. Biochem Pharmacol. 67:1469–1478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Arico S, Pattingre S, Bauvy C, et al:
Celecoxib induces apoptosis by inhibiting
3-phosphoinositide-dependent protein kinase-1 activity in the human
colon cancer HT-29 cell line. J Biol Chem. 277:27613–27621. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Hsu AL, Ching TT, Wang DS, Song X,
Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib
induces apoptosis by blocking Akt activation in human prostate
cancer cells independently of Bcl-2. J Biol Chem. 275:11397–11403.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Ostrowski J, Wocial T, Skurzak H and
Bartnik W: Do altering in ornithine decarboxylase activity and gene
expression contribute to antiproliferative properties of COX
inhibitors? Br J Cancer. 88:1143–1151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Wei D, Wang L, He Y, Xiong HQ, Abbruzzese
JL and Xie K: Celecoxib inhibits vascular endothelial growth factor
expression in and reduces angiogenesis and metastasis of human
pancreatic cancer via suppression of Sp1 transcription factor
activity. Cancer Res. 64:2030–2038. 2004. View Article : Google Scholar
|
|
43.
|
Zhang YJ, Bao YJ, Dai Q, et al: mTOR
signaling is involved in indomethacin and nimesulide suppression of
colorectal cancer cell growth via a COX-2 independent pathway. Ann
Surg Oncol. 18:580–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Wang X, Baek SJ and Eling T: COX
inhibitors directly alter gene expression: role in cancer
prevention? Cancer Metastasis Rev. 30:641–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Petrescu I and Tarba C: Uncoupling effects
of diclofenac and aspirin in the perfused liver and isolated
hepatic mitochondria of rat. Biochim Biophys Acta. 1318:385–394.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Somasundaram S, Sigthorsson G, Simpson RJ,
et al: Uncoupling of intestinal mitochondrial oxidative
phosphorylation and inhibition of cyclooxygenase are required for
the development of NSAID-enteropathy in the rat. Aliment Pharmacol
Ther. 14:639–650. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Das S, Khan N, Mukherjee S, et al: Redox
regulation of resveratrol-mediated switching of death signal into
survival signal. Free Radic Biol Med. 44:82–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Vaish V, Tanwar L and Sanyal SN: The role
of NF-kappaB and PPARgamma in experimentally induced colorectal
cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour
Biol. 31:427–436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Maier TJ, Janssen A, Schmidt R,
Geisslinger G and Grosch S: Targeting the beta-catenin/APC pathway:
a novel mechanism to explain the cyclooxygenase-2-independent
anticarcinogenic effects of celecoxib in human colon carcinoma
cells. FASEB J. 19:1353–1355. 2005.PubMed/NCBI
|
|
50.
|
Paul S, DeCastro AJ, Lee HJ, et al:
Dietary intake of pterostilbene, a constituent of blueberries,
inhibits the beta-catenin/p65 downstream signaling pathway and
colon carcinogenesis in rats. Carcinogenesis. 31:1272–1278. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Onizawa M, Nagaishi T, Kanai T, et al:
Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial
cells may be directly involved in colitis-associated
carcinogenesis. Am J Physiol Gastrointest Liver Physiol.
296:G850–G859. 2009. View Article : Google Scholar
|
